Please select the option that best describes you:
Do you have any experience with compounded iguratimod either as adjunctive therapy or monotherapy for rheumatoid arthritis, Sjogrens, or axial spondyloarthropathy?
This medication is used primarily in China and Japan and is not FDA approved in the USA.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7054862/